MARKET

ARCT

ARCT

Arcturus Therape
NASDAQ
16.41
+0.55
+3.47%
After Hours: 16.35 -0.06 -0.37% 17:45 02/13 EST
OPEN
15.94
PREV CLOSE
15.86
HIGH
16.46
LOW
15.57
VOLUME
343.42K
TURNOVER
--
52 WEEK HIGH
45.00
52 WEEK LOW
14.30
MARKET CAP
444.50M
P/E (TTM)
-7.0505
1D
5D
1M
3M
1Y
5Y
1D
Axsome (AXSM) Surges 20.2%: Is This an Indication of Further Gains?
NASDAQ · 3d ago
Weekly Report: what happened at ARCT last week (0203-0207)?
Weekly Report · 4d ago
Arcturus Therapeutics appoints Moncef Slaoui as chair designate
TipRanks · 02/04 13:55
ARCTURUS THERAPEUTICS ANNOUNCES APPOINTMENT OF MONCEF SLAOUI, PH.D., AS CHAIR DESIGNATE
Reuters · 02/04 13:30
Weekly Report: what happened at ARCT last week (0127-0131)?
Weekly Report · 02/03 12:01
What Moved Markets This Week
Seeking Alpha · 02/01 11:38
Ed Arce’s Buy Rating on Arcturus Therapeutics Driven by Strategic Advancements and Strong Market Positioning
TipRanks · 01/31 15:55
Meiji Seika Pharma Secures Approval For Domestic Manufacturing Of KOSTAIVE, Japan's First Self-Amplifying mRNA COVID-19 Vaccine
Benzinga · 01/31 08:21
More
About ARCT
Arcturus Therapeutics Holdings Inc. is a global messenger RNA medicines and vaccine company. The Company is focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. In addition to its messenger RNA (mRNA) platform, its lipid nanoparticle (LNP) delivery system, LUNAR, has the potential to enable multiple nucleic acid medicines, and its self-amplifying mRNA technology (Self-Transcribing and Replicating RNA (STARR), technology) has the potential to provide longer-lasting RNA and sustained protein expression at lower dose level. It is leveraging its LUNAR platform and its nucleic acid technologies to develop and advance a pipeline of mRNA-based vaccines and therapeutics for infectious diseases and rare genetic disorders with significant unmet medical needs. Its COVID-19 vaccine candidate, which is based on its STARR technology platform is through Phase II clinical trials.

Webull offers Arcturus Therapeutics Holdings Inc stock information, including NASDAQ: ARCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARCT stock methods without spending real money on the virtual paper trading platform.